Provisional diagnostic criteria for depression of Alzheimer's disease: Description and review

Expert Review of Neurotherapeutics

Volumn 3, Issue 1, 2003, Pages 99-106

  Olin, Jason T ^a   Schneider, Lon S ^b   Katz, Ira R ^c   Meyers, Barnett S ^d   Alexopoulos, George S ^d   Breitner, John C ^e   Bruce, Martha L ^d   Caine, Eric D ^f   Cummings, Jeffrey L ^g   Devanand, Davangere P ⁿ   Jeste, Dilip V ^h   Krishnan, K Ranga Rama ⁱ   Lyketsos, Constantine G ^j   Lyness, Jeffrey M ⁿ   Rabins, Peter V ^j   Reynolds III, Charles F ^k   Rovner, Barry W ^l   Steffens, David C ⁱ   Unützer, Jürgen ^m   Lebowitz, Barry D ⁿ  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j JOHNS HOPKINS HOSPITAL   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l WILLS EYE HOSPITAL   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UCLA Wilshire Center ^*

more..

Author keywords

Alzheimer's disease; Dementis; Depression; Diagnosis; Epidemiology; Mood; Review; SSRI; Treatment

Indexed keywords

ALZHEIMER DISEASE; CLINICAL FEATURE; CORRELATION ANALYSIS; DEPRESSION; DISEASE COURSE; ECONOMIC ASPECT; HUMAN; MEDICAL RESEARCH; NEUROBIOLOGY; REVIEW; RISK FACTOR; SYMPTOMATOLOGY;

EID: 0037224828     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.3.1.99     Document Type: Review

References (72)

1. Olin JT, Schneider LS, Katz IR et al. National Institute of Mental Health -provisional diagnostic criteria for depression of Alzheimer's disease. Am. J. Geriatr. Psychiatry 10, 125-128 (2002). • Describes the diagnostic criteria and how they were developed.
2. Olin JT, Katz IR, Meyers BS et al. National Institute of Mental Health - provisional diagnostic criteria for depression of Alzheimer's disease. Am. J. Geriatr. Psychiatry 10, 129-141 (2002). • More extensive review of the literature that supports development of the criteria for depression of AD.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, Text Revision. American Psychiatric Association Press, Washington, DC, USA (2000).
4. Zweig, RM, Ross CA, Hedreen JC. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann. Neurol. 24, 233-242 (1988).
5. Zweig RM, Ross CA, Hedreen JC et al. Neuropathology of aminergic nuclei in Alzheimer's disease. Prog. Clin. Biol. Res. 317, 353-365 (1989).
6. Forsd H, Burns A, Luthert P. Clinical and neuropathological correlates of depression in Alzheimer's disease. Pychol. Med. 22, 877-884 (1992).
7. Zubenko GS. Neurobiology of major depression in Alzheimer's disease. Int. Psychogeriatr. Suppl. 1, 217-230 (2000).
8. Zubenko GS. Do susceptibility loci contribute to the expression of more than one mental disorder? A view from the genetics of Alzheimer's disease. Mol. Psychiatry 5(2), 131-136 (2000).
9. Migliorelli R, Teson A, Sabe L et al. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am. J. Psychiatry 152, 37-44 (1995).
10. Vida S, Des Rosiers P, Carrier L et al. Prevalence of depression in Alzheimer's disease and validity of Research Diagnostic Criteria. J. Geriatr. Psychiatry Neurol. 7, 238-244 (1994).
11. Mirowsky J, Ross CE. Psychiatric diagnosis as reified measurement. J. Health Social Behavior 30, 11-25 (1989).
12. Klerman GL. Comment to Mirowsky and Ross. J. Health Social Behavior 30, 26-32 (1989).
13. Eaton WW, Neufeld K, Chen LS et al. A comparison of self-report and clinical diagnostic interviews for depression. Arch. Gen. Psychiatry 57, 217-222 (2000).
14. Murphy JM, Monson RR, Laird NM et al. A comparison of diagnostic interviews for depression in the Stirling County Study. Arch. Gen. Psychiatry 57, 230-236 (2000).
15. Regier DA. Limitations of diagnostic criteria and assessment instruments for mental disorders. Arch. Gen. Psychiatry 55, 109-115 (1998). • Useful report that highlights the need for standardized diagnostic criteria.
16. Breteler MM, Claus JJ, van Duijn CM et al. Epidemiology of Alzheimer's disease. Epidemiol. Rev. 14, 59-82 (1992).
17. Pfeffer RI, Afifi AA, Chance JM. Prevalence of Alzheimer's disease in a retirement community. Am. J. Epidemiol. 125(3), 420-436 (1987).
18. Burke WJ, Roccaforte WH, Wengel SP et al. Disagreement in the reporting of depressive symptoms between patients with dementia of the Alzheimer type and their collateral sources. Am. J. Geriatr. Psychiatry 6(4), 308-319 (1998).
19. Harwood DG, Sultzer DL, Wheatley MV. Impaired insight in Alzheimer's disease: association with cognitive deficits, psychiatric symptoms and behavioral disturbances. Neuropsychiatry Neuropsychol Behav. Neurol 13(2), 83-88 (2000).
20. Merriam AE, Aronsson MK, Gaston P et al. The psychiatric symptoms of Alzheimer's disease. J. Am. Geriatr. Soc. 35, 7-17 (1988).
21. Burke WJ, Rubin EH, Morris JC et al. Symptoms of 'depression' in dementia of the Alzheimer type. Alz. Dis. Assoc. Disorders 2(4), 356-362 (1988).
22. Verhey FRJ, Rozendaal N, Ponds RWHM et al. Dementia, awareness and depression. Int. J. Geriatr. Psychiatry 8, 851-856 (1993).
23. Verhey FR, Ponds RW, Rozendaal N et al. Depression, insight and personality changes in Alzheimer's disease and vascular dementia. J. Geriatr. Psychiatry Neurol. 8(1), 23-27 (1995).
24. Payne JL, Lyketsos CG, Baker L et al. The relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias. J. Neuropsychiatry Clin. Neurosci. 10, 440-447 (1998).
25. Ballard C, Bannister C, Solis M et al. The prevalence, association and symptoms of depression amongst dementia sufferers. J. Affect Disord. 36, 136-144 (1996).
26. Devanand DP, Jacobs DM, Tang M-X et al. The course of psychopathologic symptoms in mild to moderate Alzheimer's disease. Arch. Gen. Psychiatry 54, 257-263 (1997).
27. Chemerinski E, Petracca G, Sabe L et al. Specificity of depressive symptoms in Alzheimer's disease. Am. J. Psychiatry 158, 68-72 (2001).
28. Patterson MB, Schnell AH, Martin RJ et al. Assessment of behavioral and affective symptoms in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 3(1), 21-30 (1990).
29. Merriam AE, Aronson MK, Gaston P et al. The psychiatric symptoms of Alzheimer's disease. J. Am. Geriatr. Soc. 36(1), 7-12 (1988).
30. Forsell Y, Jorm AF, Winblad B. Variation in psychiatric and behavioural symptoms at different stages of dementia: data from physicians' examinations and informants' reports. Dementia 4(5), 282-286 (1993).
31. Levy ML, Cummings JL, Fairbanks LA et al. Longitudinal assessment of symptoms of depression, agitation and psychosis in 181 patients with Alzheimer's disease. Am. J. Psychiatry 153(11), 1438-1443 (1996).
32. Starkstein SE, Chemerinski E, Sabe L et al. Prospective longitudinal study of depression and anosognosia in Alzheimer's disease. Br. J. Psychiatry 171, 47-52 (1997).
33. Bassuk SS, Berkman LF, Wypiy D. Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch. Gen. Pychiatry 55, 1073-1081 (1998).
34. Hoch CC, Reynolds CF, Buysse DJ et al. Two-year survival in patients with mixed symptoms of depression and cognitive impairment: Comparison with major depression and primary degenerative dementia. Am. J. Geriatr. Psychiatry 1 (1), 59-66 (1993).
35. Rubio A, Vestner AL, Stewart JM et al. Suicide and Alzheimer's pathology in the elderly: a case-control study. Biol. Psychiatry 49(2), 137-145 (2001).
36. Reisberg B, Auer SR, Monteiro M. Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. Int. Psychogeriatr. 3, 301-308 (1996).
37. Devanand DP, Miller L, Richards M et al. The Columbia University Scale for the Psychopathology of Alzheimer's disease. Arch. NeuroL 49, 371-376 (1992).
38. Cummings JL, Mega M, Gray K et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314 (1994). • One of the most commonly-used behavioral scales in dementia trials.
39. Petracca G, Teson A, Chemrinski E et al. A Double-blind placebo-controlled study of domipramine in depressed patients with Alzheimer's disease. J. Neuropsychiatry Clin. Neurosci. 8, 270-275 (1996).
40. Roth M, Mountjoy CQ, Amriein P, Moclobemide in elderly patients with cognitive decline and depression. Br. J. Psychiatry 168, 149-157 (1996).
41. Lyketsos CG, Sheppard JE, Steele CD et al. Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: Initial results from the depression in Alzheimer's disease Study. Am. J. Psychiatry 157, 1686-1689 (2000).
42. Maixner SM, Burke WJ, Roccaforte WH et al. A comparison of two depression scales in a geriatric assessment clinic. Am. J. Psychiatry 153, 60-67 (1995).
43. Lichtenberg PA, Steiner DA, Marcopulos BA et al. Comparison of the Hamilton depression rating scale and the geriatric depression scale: detection of depression in dementia patients. Psychological Reports 70, 515-521 (1992).
44. Miller NE. The measurement of mood in senile brain disease. Examiner ratings and self-reports. In: Psychopathology in the Aged. Cole JO, Barrett JE (Eds). Raven Press, New York, USA, 97-12, (1980).
45. Alexopoulos GS, Abrams RC, Young RC et al. Cornell scale for depression in dementia. Biol. Psychiatry 23, 271-284 (1988). • One of the few scales designed to assess depression in demented subjects.
46. Alexopoulos GS, Abrams RC, Young RC et al. Use of the Cornell scale in nondemented patients. J. Am. Geriatr. Soc. 36, 230-236 (1988).
47. Sunderland T, Alterman IS, Yount D et al. A new scale for the assessment of depressed mood in dementia patients. Am. J. Psychiatry 152, 1349-1357 (1988).
48. Katona CLE, Aldridge CR. The dexamethasone suppression test and depressive signs in dementia. J. Affect. Disord 8, 89-89 (1985).
49. Lawton MP, Van Haitsma K, Klapper J. Observed affect in nursing home residents with Alzheimer's disease. J. Gerontol. B Psychol. Sci. Soc. Sci. 51, P3-14 (1996).
50. Magai C, Cohen C, Gomberg D et al. Emotional expression during mid-to late-stage dementia. Int. Psychogeriatr. 8, 383-395 (1996).
51. Montgomery SA, Asberg M, Jornestedt L. Reliability of the CPRS between disciplines of psychiatry, general practice, nursing and psychology in depressed patients. Acta Pychiatr Scand Suppl. 271, 29-32 (1978).
52. Reifler BV, Teri L, Raskind M et al. Double-blind trial of imipramine in Alzheimer's patients with and without depression. Am. J. Pychiatry 146, 45-49 (1989).
53. Zubenko GS, Rosen J, Sweet RA et al. Impact of psychiatric hospitalization on behavioral complications of Alzheimer's disease. Am. J. Psychiatry 149 (11), 1484-1491 (1992).
54. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Alzheimer's disease and Other Dementias of Late Life. American Psychiatric Press (1997).
55. Rabins PV, Lyketsos CG, Steele CD. Practical Dementia Care. Oxford Press (1999).
56. Alexopoulos GS, Silver JM, Frances A: Treatment of agitation in older persons with dementia. Postgrad. Med. April (1998).
57. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: A Nordic multicentre study. Br. J. Psychiatry 157, 894-901 (1990).
58. Nyth AL, Gotffries CG, Lyby K et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr. Scand. 86, 138-145 (1992).
59. Magai C, Kennedy G, Cohen CI et al. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. Am J. Geriatr. Pychiatry 8(1), 66-74 (2000).
60. Petracca GM, Chemerinski E, Starkstein SE. A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease. Int. Pychogeriatrics 13(2), 233-240 (2001).
61. Katona CL, Hunter BN, Bray J. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia. Int. J. Geriar. Psychiatry 13, 100-108 (1998).
62. Taragano FE, Lyketsos CG, Mangone CA et al. Double-blind, randomized, fixed dose trial of fluoxetine versus amitriptyline in the treatment of major depression complicating Alzheimer's disease. Psychosomatics 38, 246-252 (1997).
63. Teri L, Logsdon RG, Uomoto J et al. Behavioral treatment of depression in dementia patients: a controlled clinical trial. J. Gerontol. B Psychol. Sci. Soc. Sci. 52(4), 159-166 (1997).
64. Rao V, Lyketsos CG. The benefits and risks of ECT for patients with degenerative dementia who also suffer from depression. Int. J. Ger. Pychiatry 15, 729-735 (2000).
65. Unützer J, Patrick DL, Simon G et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA 277(20), 1618-1623 (1997).
66. Weiner M, Powe NR, Weller WE et al. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J. Am. Geriatr. Soc. 46(6), 762-770 (1998).
67. Souetre E, Thwaites RM, Yeardley HL. Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease. Br. J. Psychiatry 174, 51-55 (1999).
68. Leon J, Neumann PJ. The cost of Alzheimer's disease in managed care: a cross-sectional study. Am. J. Manag. Care 5(7), 867-877 (1999).
69. Boada M, Pena-Casanova J, Bermejo F et al. Costs of healthcare resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain. Med. Clin. (Barc.) 113(18), 690-695 (1999).
70. Livingston G, Manela M, Katona C. Cost of community care for older people. Br. J. Psychiatry 171, 56-59 (1997).
71. Meltzer CC, Smith G, DeKosky ST et al. Serotonin in aging, late-life depression and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18(6), 407-430 (1998).
72. Mossner R, Schmitt A, Syagailo Y et al. The serotonin transporter in Alzheimer's and Parkinson's disease. J. Neural Transm. Suppl. (60), 345-350 (2000).